TrialPharmacogenetics and genomics2018
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
James N Ingle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it